TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract March 16, 1984
TCL Archive An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves November 13, 1998